Evidence map›Paper›PMID 40419482›Full record

ArticleSchizophrenia (Heidelberg, Germany)2025

Toxoplasma gondii associated with psychotic symptom load and cortisol in severe mental illness.

Dimitrios Andreou, Nils Eiel Steen, Kjetil Nordbø Jørgensen, Stener Nerland, Thor Ueland, Laura A Wortinger, Ina Drabløs, Tereza Calkova, Monica B E G Ormerod, Linn Sofie Sæther and 3 more

Abstract read
In one paragraph

Article in Schizophrenia (Heidelberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Cerebral toxoplasmosis: Parasitology, diagnosis, treatment, and prevention - a narrative review.Current research in parasitology & vector-borne diseases · 2026
    Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Dimitrios AndreouDivision of Mental Health and Substance Abuse, Diakonhjemmet Hospital, Oslo, Norway. dimitrios.andreou@ki.se.ORCID http://orcid.org/0000-0003-4735-3383
Nils Eiel SteenDivision of Mental Health and Substance Abuse, Diakonhjemmet Hospital, Oslo, Norway.ORCID http://orcid.org/0000-0001-6442-1179
Kjetil Nordbø JørgensenInstitute of Clinical Medicine, University of Oslo, Oslo, Norway.ORCID http://orcid.org/0000-0002-5751-4809
Stener NerlandDivision of Mental Health and Substance Abuse, Diakonhjemmet Hospital, Oslo, Norway.ORCID http://orcid.org/0000-0001-8771-8856
Thor UelandInstitute of Clinical Medicine, University of Oslo, Oslo, Norway.
Laura A WortingerDivision of Mental Health and Substance Abuse, Diakonhjemmet Hospital, Oslo, Norway.ORCID http://orcid.org/0000-0003-2721-3172
Ina DrabløsDivision of Mental Health and Substance Abuse, Diakonhjemmet Hospital, Oslo, Norway.
Tereza CalkovaCentre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet & Stockholm Health Care Services, Stockholm Region, Stockholm, Sweden.
Monica B E G OrmerodDivision of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
Linn Sofie SætherInstitute of Clinical Medicine, University of Oslo, Oslo, Norway.
Ole A AndreassenDivision of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.ORCID http://orcid.org/0000-0002-4461-3568
Robert H YolkenStanley Division of Developmental Neurovirology, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Ingrid AgartzDivision of Mental Health and Substance Abuse, Diakonhjemmet Hospital, Oslo, Norway.

Funding

Ministry of Health and Care Services | Helse Sør-Øst RHF (Southern and Eastern Norway Regional Health Authority) 2019-108Ministry of Health and Care Services | Helse Sør-Øst RHF (Southern and Eastern Norway Regional Health Authority) 2023-060Norges Forskningsråd (Research Council of Norway) 223273
6 · The paper itself

Abstract

Toxoplasma gondii (TG) is a prevalent parasite that establishes lifelong latency after primary infection. TG has been linked to severe mental illness (SMI), potentially through dopamine dysregulation in the brain. There is a bidirectional interaction between dopamine and the hypothalamic-pituitary-adrenal axis, where dopamine may influence cortisol regulation and cortisol may affect dopamine release. We hypothesised that TG would be associated with elevated circulatory cortisol levels, increased severity of psychotic symptoms, and structural brain aberrations in SMI. Our study included 765 patients with SMI (515 with schizophrenia spectrum disorders and 250 with bipolar disorders) and 541 healthy controls (HC). TG immunoglobulin G seropositivity and circulatory cortisol concentrations were measured with immunoassays, and T1-weighted MRI scans were processed using FreeSurfer. Psychotic symptom scores were evaluated using the Positive and Negative Syndrome Scale. In SMI, TG seropositivity was associated with higher cortisol levels (p = 0.002), but not in HC. Seropositive patients had lower total psychotic symptom scores (p = 0.006) than seronegative patients, driven by the schizophrenia subgroup (p = 0.002). This effect was observed for positive, negative, and general psychotic symptom scores, but only for patients with an illness duration of 10 years or more. In an exploratory analysis, TG seropositivity was nominally associated with smaller thalamus, nucleus accumbens, and middle temporal volumes in SMI, and with smaller fusiform, parahippocampal, and pars triangularis volumes in HC. In conclusion, TG exposure in SMI was linked to elevated cortisol levels and reduced psychotic symptom scores, suggesting that its impact on SMI may be more complex and context-dependent than previously assumed.

Identifiers

PMID40419482
PMCPMC12106729

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.